Vanessa Wild

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions

Epigenetics-targeted drugs: current paradigms and future challenges

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome